Navigation Links
CAMR Applauds President Obama's Commitment to Embryonic Stem Cell Research
Date:3/9/2009

WASHINGTON, March 9 /PRNewswire-USNewswire/ -- The following statement may be attributed to Amy Comstock Rick, president, Coalition for the Advancement of Medical Research (CAMR):

"For the past eight years, Americans of all backgrounds have stood together in opposition to a restrictive policy that put politics ahead of science and delayed the potential breakthrough discoveries that could forever change how we treat diseases. Today, thanks to the action taken by President Obama, we stand in triumph. By signing an Executive Order that calls for funding and appropriate ethical oversight for embryonic stem cell research, President Obama has ensured that Americans are no longer forced to look back at what could have been, but can instead look forward to one day seeing the promise of scientific and medical research fulfilled.

"President Obama has replaced eight years of frustration with a renewed sense of hope and optimism for the 100 million Americans suffering from cancer, Parkinson's, Alzheimer's, diabetes, spinal cord injuries, and other debilitating diseases and disorders.

"Nearly three-quarters of Americans, the majority of both the House and the Senate, and now the President of the United States support federal funding for embryonic stem cell research.

"With so many pressing domestic and world policy issues on the agenda, we are proud of the President's action, and are thankful he chose to stand up for the health, hope and well being of millions of Americans, their families, friends, and caregivers, in making this Executive Order a priority this early in his administration.

"We look forward to working with the 111th Congress and HHS and NIH leadership to continue to move this issue forward, and ensure America's researchers are able to pursue embryonic stem cell research with appropriate ethical guidelines and oversight."

The following may be attributed to Michael J. Fox, founder and chairman, Michael J. Fox Foundation for Parkinson's Research:

"Today is a new day. I could not be more thrilled to see President Obama live up to his commitment to get politics out of science. We have seen, for the past eight years, how much damage the opposite approach has done to science and patients. Now that the President has taken this critical action, I am excited by the prospect of American scientists carrying human embryonic stem cell research forward toward better treatments and cures that will affect countless millions of lives.

"I commend the President for recognizing the inherent value of scientific freedom, and for helping to create an environment in which it can flourish."


'/>"/>
SOURCE Coalition for the Advancement of Medical Research
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ASPS Applauds Introduction of Legislation to Increase Access to Reconstructive Surgery for Children
2. CPTA Applauds Legislation to Ease Patient Access to Physical Therapy Services
3. National Medical Association Applauds President Obama for Convening the White House Forum on Health Reform
4. Council for Quality Respiratory Care Applauds President Obamas Appointments of Governor Sebelius, DeParle to Lead Health Care Efforts
5. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Selection of Gov. Sebelius for Secretary of Health and Human Services
6. UPDATED: DGA Leadership Applauds Gov. Sebelius Cabinet Appointment
7. DGA Chair Gov. Schweitzer Applauds Gov. Sebelius Cabinet Appointment
8. APHA Applauds Inclusion of Health Reform Fund in Presidents Budget
9. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Obama for Commitment to Health Reform, Cancer Research, in Budget Blueprint
10. Partnership Applauds President for Shining Light on True Cost Driver in Health Care - Calls on CBO to Join the Effort
11. AIDS Action Applauds President on Appointment of Jeffrey Crowley as Director of National AIDS Policy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based insurance ... is spearheading a regional charity campaign organized to provide support to Christina Upchurch and ... this year, Christina and her children returned from out of town to find her ...
(Date:8/18/2017)... Raton, Fl (PRWEB) , ... August 18, 2017 ... ... largest network of highly trained practitioners specializing in bioidentical hormone replacement therapy and ... associated with hormone imbalance and conditions of aging, such as menopause, andropause, thyroid ...
(Date:8/18/2017)... ... ... Alcovit, a lime-flavored beverage that rids the body of toxins linked to ... available through Jet.com. , After 25 years of development, the company released its ... quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with friends ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... and call tracking and monitoring solutions, announced today the launch of a redesigned ... a modern navigation and aesthetic, fully responsive design, and an enhanced search directory ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about saving the family ... is from Southwest Nebraska where she was raised on a farm. As Diane ... is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ have always been ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of ... to be in the beginning stages of an IPO. ... epilepsy medications with the average cost of a prescription epilepsy drug being ... AXIUM ... Another staggering figure is the fact that ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
Breaking Medicine Technology: